383 related articles for article (PubMed ID: 19500272)
1. Does pain cause the perception of fatigue in patients with chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall JA; Risser RC; Gonzales JS
Pain Pract; 2009; 9(5):354-62. PubMed ID: 19500272
[TBL] [Abstract][Full Text] [Related]
2. Does pain mediate the pain interference with sleep problem in chronic pain? Findings from studies for management of diabetic peripheral neuropathic pain with duloxetine.
Fishbain DA; Hall J; Meyers AL; Gonzales J; Mallinckrodt C
J Pain Symptom Manage; 2008 Dec; 36(6):639-47. PubMed ID: 18504092
[TBL] [Abstract][Full Text] [Related]
3. What makes patients with fibromyalgia feel better? Correlations between Patient Global Impression of Improvement and changes in clinical symptoms and function: a pooled analysis of 4 randomized placebo-controlled trials of duloxetine.
Hudson JI; Arnold LM; Bradley LA; Choy EH; Mease PJ; Wang F; Ahl J; Wohlreich MM
J Rheumatol; 2009 Nov; 36(11):2517-22. PubMed ID: 19833743
[TBL] [Abstract][Full Text] [Related]
4. Impact of disease characteristics on the efficacy of duloxetine in diabetic peripheral neuropathic pain.
Ziegler D; Pritchett YL; Wang F; Desaiah D; Robinson MJ; Hall JA; Chappell AS
Diabetes Care; 2007 Mar; 30(3):664-9. PubMed ID: 17327338
[TBL] [Abstract][Full Text] [Related]
5. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
[TBL] [Abstract][Full Text] [Related]
6. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?
Russell JW
Nat Clin Pract Neurol; 2006 Jan; 2(1):18-9. PubMed ID: 16932514
[No Abstract] [Full Text] [Related]
7. Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Lee P; Shu L; Xu X; Wang CY; Lee MS; Liu CY; Hong JP; Ruschel S; Raskin J; Colman SA; Harrison GA
Psychiatry Clin Neurosci; 2007 Jun; 61(3):295-307. PubMed ID: 17472599
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms.
Russell JM; Weisberg R; Fava M; Hartford JT; Erickson JS; D'Souza DN
Depress Anxiety; 2008; 25(7):E1-11. PubMed ID: 17587217
[TBL] [Abstract][Full Text] [Related]
9. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression.
Shelton RC; Prakash A; Mallinckrodt CH; Wohlreich MM; Raskin J; Robinson MJ; Detke MJ
Int J Clin Pract; 2007 Aug; 61(8):1337-48. PubMed ID: 17627710
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of duloxetine in painful symptoms: an analgesic or antidepressant effect?
Perahia DG; Pritchett YL; Desaiah D; Raskin J
Int Clin Psychopharmacol; 2006 Nov; 21(6):311-7. PubMed ID: 17012978
[TBL] [Abstract][Full Text] [Related]
11. Comparisons of the efficacy and safety of duloxetine for the treatment of fibromyalgia in patients with versus without major depressive disorder.
Arnold LM; Hudson JI; Wang F; Wohlreich MM; Prakash A; Kajdasz DK; Chappell AS
Clin J Pain; 2009; 25(6):461-8. PubMed ID: 19542792
[TBL] [Abstract][Full Text] [Related]
12. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain.
Skljarevski V; Desaiah D; Zhang Q; Chappell AS; Detke MJ; Gross JL; Ziegler D
Diabetes Metab Res Rev; 2009 Oct; 25(7):623-31. PubMed ID: 19637208
[TBL] [Abstract][Full Text] [Related]
13. Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Gaynor P; McCarberg B; Zheng W; Shoemaker S; Duenas H
Int J Clin Pract; 2011 Mar; 65(3):341-9. PubMed ID: 21314871
[TBL] [Abstract][Full Text] [Related]
14. Randomized study of tramadol/acetaminophen versus placebo in painful diabetic peripheral neuropathy.
Freeman R; Raskin P; Hewitt DJ; Vorsanger GJ; Jordan DM; Xiang J; Rosenthal NR;
Curr Med Res Opin; 2007 Jan; 23(1):147-61. PubMed ID: 17257476
[TBL] [Abstract][Full Text] [Related]
15. Safety and tolerability of duloxetine in the acute management of diabetic peripheral neuropathic pain: analysis of pooled data from three placebo-controlled clinical trials.
Hall JA; Wang F; Oakes TM; Utterback BG; Crucitti A; Acharya N
Expert Opin Drug Saf; 2010 Jul; 9(4):525-37. PubMed ID: 20465525
[TBL] [Abstract][Full Text] [Related]
16. Time course of depression-symptom improvement during treatment with duloxetine.
Hirschfeld RM; Mallinckrodt C; Lee TC; Detke MJ
Depress Anxiety; 2005; 21(4):170-7. PubMed ID: 16035056
[TBL] [Abstract][Full Text] [Related]
17. Duloxetine treatment and glycemic controls in patients with diagnoses other than diabetic peripheral neuropathic pain: a meta-analysis.
Crucitti A; Zhang Q; Nilsson M; Brecht S; Yang CR; Wernicke J
Curr Med Res Opin; 2010 Nov; 26(11):2579-88. PubMed ID: 20874076
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy of generalized anxiety disorder: results of duloxetine treatment from a pooled analysis of three clinical trials.
Allgulander C; Hartford J; Russell J; Ball S; Erickson J; Raskin J; Rynn M
Curr Med Res Opin; 2007 Jun; 23(6):1245-52. PubMed ID: 17559726
[TBL] [Abstract][Full Text] [Related]
19. Maintenance of effect of duloxetine in patients with chronic low back pain: a 41-week uncontrolled, dose-blinded study.
Skljarevski V; Zhang S; Chappell AS; Walker DJ; Murray I; Backonja M
Pain Med; 2010 May; 11(5):648-57. PubMed ID: 20546509
[TBL] [Abstract][Full Text] [Related]
20. The short- and long-term effect of duloxetine on painful physical symptoms in patients with generalized anxiety disorder: results from three clinical trials.
Beesdo K; Hartford J; Russell J; Spann M; Ball S; Wittchen HU
J Anxiety Disord; 2009 Dec; 23(8):1064-71. PubMed ID: 19643572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]